Enveric Biosciences (ENVB) Acquisitions (2016 - 2019)
Enveric Biosciences (ENVB) posted Acquisitions of $100000.0 for Q2 2019, little changed sequentially from $100000.0 in Q1 2019, and up 9999900.0% YoY from N/an in Q2 2018.
Enveric Biosciences (ENVB) Acquisitions (2016 - 2019) Analysis & Trends
Enveric Biosciences has reported Acquisitions for 4 years, with the latest figure at $100000.0 in Q2 2019.
- Quarterly Acquisitions rose 9999900.0% year-over-year to $100000.0 in Q2 2019, while the trailing twelve-month figure through Mar 2020 was $100000.0 (down 96.26% YoY) and the FY2021 annual result came in at $3.1 million, changed N/A from the prior year.
- Acquisitions held at $100000.0 in Q2 2019 per ENVB's latest filing, from $100000.0 in the prior quarter.
- Over five years, Acquisitions peaked at $5.5 million in Q3 2016 and troughed at -$2.2 million in Q4 2016.
- A 4-year average of $810261.8 and a median of $100000.0 in 2019 frame the typical range for Acquisitions.
- The sharpest annual moves came in 2018 and 2019: Acquisitions sank 100.0% in 2018, then jumped 9999900.0% in 2019.
- Over 4 years, Acquisitions stood at -$2.2 million in 2016, then surged by 100.19% to $4313.0 in 2017, then sank by 99.98% to $1.0 in 2018, then surged by 9999900.0% to $100000.0 in 2019.
- According to Business Quant data, Acquisitions over the past three periods registered $100000.0, $100000.0, and $1.0 for Q2 2019, Q1 2019, and Q4 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Enveric Biosciences | 5.42 Mn | -2.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 100,000.00 |
| Dec 31, 2018 | 1.00 |
| Sep 30, 2018 | 2.58 Mn |
| Jun 30, 2018 | 1.00 |
| Mar 31, 2018 | 1.07 Mn |
| Dec 31, 2017 | 4,313.00 |
| Jun 30, 2017 | 64,736.00 |
| Mar 31, 2017 | 55,687.00 |
| Dec 31, 2016 | -2.22 Mn |
| Sep 30, 2016 | 5.55 Mn |
| Jun 30, 2016 | 1.51 Mn |
| Mar 31, 2016 | 1.72 Mn |